MarketCap
Facebook
X
TelegramAnnual report 2022
added 03-30-2023
HTG Molecular Diagnostics ROE Ratio 2011-2026 | HTGM
Annual ROE Ratio HTG Molecular Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -400.51 | -164.86 | -144.08 | -80.51 | -78.01 | 619.7 | 465.59 | -126.66 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 619.7 | -400.51 | 11.33 |
Quarterly ROE Ratio HTG Molecular Diagnostics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -537.12 | -567.28 | -223.71 | -132.17 | -73.13 | -110.5 | -117.69 | -142.94 | -114.47 | -134.24 | -116.66 | -97.25 | -62.2 | -85.16 | -88.35 | -87.78 | -67.92 | 107.95 | 306.78 | 517.14 | 556.88 | 672.9 | 613.04 | 544.64 | 364.15 | 333.62 | 187.08 | 26.38 | -92.92 | -88.18 | -52.9 | -9.42 | 14.09 | 14.09 | 9.35 | 4.06 | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 672.9 | -567.28 | 35.28 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 19.89 | 10.93 % | $ 211 M |  China |
 |
Agilent Technologies
A
|
22.45 | $ 120.39 | 2.46 % | $ 36.6 B |  USA |
 |
Aspira Women's Health
AWH
|
184.36 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M |  Israel |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
CareDx, Inc
CDNA
|
-7.05 | $ 17.63 | 4.75 % | $ 939 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
-227.33 | $ 1.38 | -4.83 % | $ 1.84 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.66 | - | - | $ 19.8 B | USA |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | USA |
 |
Castle Biosciences
CSTL
|
4.0 | $ 24.37 | 3.57 % | $ 677 M | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
-4.56 | $ 179.31 | 0.54 % | $ 8.89 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
Interpace Biosciences
IDXG
|
109.89 | $ 2.2 | - | $ 9.73 M | USA |
 |
Danaher Corporation
DHR
|
6.88 | $ 198.61 | 1.4 % | $ 142 B | USA |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
Illumina
ILMN
|
-51.54 | $ 130.32 | 2.65 % | $ 20.7 B | USA |
 |
Medpace Holdings
MEDP
|
98.27 | $ 520.0 | 3.74 % | $ 15 B | USA |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 16.02 | 4.71 % | $ 484 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
9.97 | $ 29.09 | 1.89 % | $ 20 B |  Niderland |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |
 |
Guardant Health
GH
|
419.18 | $ 86.4 | 5.1 % | $ 10.8 B | USA |
 |
QIAGEN N.V.
QGEN
|
11.25 | - | - | $ 10.6 B | Niderland |
 |
Myriad Genetics
MYGN
|
-99.43 | $ 4.91 | 6.97 % | $ 455 M | USA |
 |
Anixa Biosciences
ANIX
|
-72.07 | $ 2.88 | 1.05 % | $ 93.5 K | USA |
 |
Biomerica
BMRA
|
-121.14 | $ 2.1 | 0.96 % | $ 4.82 M | USA |
 |
Senseonics Holdings
SENS
|
-113.21 | $ 6.75 | 0.45 % | $ 282 M | USA |
 |
ICON Public Limited Company
ICLR
|
8.31 | $ 113.06 | 2.44 % | $ 9.33 B |  Irlanda |
 |
NeoGenomics
NEO
|
-12.91 | $ 8.35 | 4.38 % | $ 1.07 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 268.87 | 1.78 % | $ 22.4 B | USA |
 |
Celcuity
CELC
|
-176.06 | $ 120.85 | 0.37 % | $ 5.65 B | USA |
 |
Neogen Corporation
NEOG
|
-52.72 | $ 9.61 | 5.14 % | $ 2.08 B | USA |
 |
Lantheus Holdings
LNTH
|
21.43 | $ 82.74 | 1.31 % | $ 5.58 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 194.16 | 0.65 % | $ 21.6 B | USA |
 |
Natera
NTRA
|
-77.62 | $ 214.64 | 6.31 % | $ 21.1 B | USA |
 |
ENDRA Life Sciences
NDRA
|
-310.93 | $ 4.96 | -4.43 % | $ 3.9 M | USA |
 |
Invitae Corporation
NVTA
|
-98.02 | - | - | $ 21.2 M | USA |
 |
National Research Corporation
NRC
|
82.92 | $ 17.04 | 1.34 % | $ 381 M | USA |
 |
Organovo Holdings
ONVO
|
-23.71 | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
162.49 | - | -16.95 % | $ 1.54 M | USA |